Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 13,128,768
- Share change
- +121,182
- Total reported value
- $35,591,000
- Price per share
- $2.71
- Number of holders
- 17
- Value change
- +$338,711
- Number of buys
- 7
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.6%
|
5,940,796
|
$14,377,000 | — | 31 Dec 2020 | |
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
3.8%
|
4,824,883
|
$11,676,000 | — | 31 Dec 2020 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.99%
|
1,263,408
|
$3,330,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
0.45%
|
576,500
|
$1,395,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
133,215
|
$322,000 | — | 31 Dec 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
100,000
|
$242,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
49,077
|
$118,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
25,700
|
$62,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
23,037
|
$56,000 | — | 31 Dec 2020 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
15,000
|
$36,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
14,828
|
$36,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,414
|
$28,000 | — | 31 Dec 2020 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.01%
|
11,500
|
$27,000 | — | 31 Dec 2020 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$24,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,228
|
$13,000 | — | 31 Dec 2020 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
2,000
|
$4,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 31 Dec 2020 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q1 2021
As of 31 Mar 2021,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,128,768 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, WealthTrust Axiom LLC, and BlackRock Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
17
Q1 2021 holders
17
Holder diff
0
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.